Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141<sup>+</sup> dendritic cells to activate naïve and memory WT1-specific CD8<sup>+</sup> T cells.

Clin Transl Immunology · 2020 · PMC7292901 · PMID 32547743

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Of note, DEC‐205‐WT1 stained with greater intensity than CLEC9A‐WT1 in all donors, although this trend did not reach statistical significance (Figure 2a and b ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141&lt;sup&gt;+&lt;/sup&gt; dendritic cells to activate naïve and memory WT1-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cells.

The sentences

Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141<sup>+</sup> dendritic cells to activate naïve and memory WT1-specific CD8<sup>+</sup> T cells.